(Q48401064)
Statements
1 reference
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study (English)
1 reference
A M Di Giacomo
L Pilla
R Ridolfi
E Simeone
L Orgiano
G Spadola
D Annesi
C Maccalli
E Fonsatti
G Parmiani
23 December 2014
1 reference